Reports Q3 revenue $38.99B, consensus $36.72B. CEO Tim Wentworth said: “Third quarter results reflect continued improvement in our U.S. Healthcare segment and benefits from our cost savings initiatives, while we continued to see weakness in our U.S. front-end sales. We remain focused on our turnaround plan, which will require time, disciplined focus and a balanced approach to manage future cash needs with investments necessary to navigate an evolving pharmacy and retail environment.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Unusually active option classes on open June 25th
- Is Walgreens Boots Alliance (WBA) a Good Stock to Buy before Earnings?
- Walgreens Boots Alliance Inc. (WBA) Q3 Earnings Cheat Sheet
- Options Volatility and Implied Earnings Moves This Week, June 23 – June 27, 2025
- Walgreens, Authentic Brands evaluate Rite Aid assets, Reuters says